Prot# 20062040//NU0714: A Randomized Phase II Study of Dual Epidermal Growth Factor Receptor Inhibition with Erlotinib and Panitumumab With or Without Irinotecan as Second Line Therapy in Patients with Metastatic Colorectal Cancer
- Benson III, Al B (PD/PI)
- Mulcahy, Mary Frances (Co-PD/PI)
Project: Research project